190 related articles for article (PubMed ID: 12209999)
1. Role of Wnt pathway in medulloblastoma oncogenesis.
Yokota N; Nishizawa S; Ohta S; Date H; Sugimura H; Namba H; Maekawa M
Int J Cancer; 2002 Sep; 101(2):198-201. PubMed ID: 12209999
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization and mutation of beta-catenin in medulloblastomas.
Eberhart CG; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
[TBL] [Abstract][Full Text] [Related]
3. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN
Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
8. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
9. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
10. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
[TBL] [Abstract][Full Text] [Related]
11. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
12. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
[TBL] [Abstract][Full Text] [Related]
13. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
14. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis.
Kang DE; Soriano S; Xia X; Eberhart CG; De Strooper B; Zheng H; Koo EH
Cell; 2002 Sep; 110(6):751-62. PubMed ID: 12297048
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
16. CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
Silva Rd; Marie SK; Uno M; Matushita H; Wakamatsu A; Rosemberg S; Oba-Shinjo SM
Clinics (Sao Paulo); 2013; 68(2):167-72. PubMed ID: 23525311
[TBL] [Abstract][Full Text] [Related]
17. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
Willert K; Shibamoto S; Nusse R
Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
[TBL] [Abstract][Full Text] [Related]
18. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
19. Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin.
Imai M; Nakamura T; Akiyama T; Horii A
Oncol Rep; 2004 Nov; 12(5):1099-103. PubMed ID: 15492799
[TBL] [Abstract][Full Text] [Related]
20. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
Yeh KT; Chang JG; Lin TH; Wang YF; Chang JY; Shih MC; Lin CC
Int J Oncol; 2003 Oct; 23(4):1001-7. PubMed ID: 12963979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]